Albendazole versus metronidazole in the treatment of patients with giardiasis in the Islamic Republic of Iran
AbstractWe examined the therapeutic effects of albendazole compared to metronidazole in 120 patients with giardiasis in Hamdan. Patients were randomized to receive albendazole [400 mg, once daily for 5 days] or metronidazole [250 mg, 3 times a day for 5 days]. Demographic data of the patients, results of stool for Giardia trophozoites before and after treatment, and drug side- effects were recorded. After treatment 6 [10.0%] of the albendazole group had trophozoites compared with 14 [23.3%] of metronidazole group [P < 0.05]. Patients in the albendazole group had fewer side- effects while 43.3% of the metronidazole group experienced a metallic taste and 35.0% experienced loss of appetite. Albendazole is an easy, safe and effective treatment for giardiasis
Alizadeh, A., Ranjbar, M., Kashani, K.M., Taheri, M.M. & Bodaghi, M. (2006). Albendazole versus metronidazole in the treatment of patients with giardiasis in the Islamic Republic of Iran. EMHJ - Eastern Mediterranean Health Journal, 12 (5), 548-554, 2006 http://www.who.int/iris/handle/10665/117116
JournalEMHJ - Eastern Mediterranean Health Journal, 12 (5), 548-554, 2006
MetadataShow full item record
Showing items related by title and MeSH subject.